OCTRODE PERCUTANEOUS LEAD
Report
- Report Number
- 1627487-2010-01777
- Event Type
- Injury
- Date Received
- September 13, 2010
- Date of Event
- May 12, 2008
- Report Date
- May 13, 2008
- Manufacturer
- ADVANCED NEUROMODULATION SYSTEMS
- Product Code
- LGW
- PMA / PMN Number
- P010032
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
EVALUATION: THE DEVICE HISTORY AND STERILIZATION RECORDS WERE REVIEWED. RESULTS: THE DEVICE HISTORY AND STERILIZATION RECORDS REVIEWED WERE FOUND TO MEET SPECIFICATIONS AND NO ANOMALIES WERE FOUND. CONCLUSION: THE CAUSE OF THE REPORTED COMPLAINT COULD NOT BE DETERMINED FROM THE REVIEW OF THE DHR AND STERILIZATION RECORDS. THIS MDR IS BEING SUBMITTED PAST THE 30 DAYS REPORTING REQUIREMENT AS PART OF A RETROSPECTIVE REVIEW INITIATED IN RESPONSE TO AN FDA INSPECTION. A RETROSPECTIVE REVIEW OF THE COMPLAINT RECORD DETERMINED THAT ANS MISINTERPRETED THE MDR REGULATIONS IN THIS INSTANCE. ANS HAS LIMITED INFORMATION RELATED TO THE PATIENT'S MEDICAL HISTORY AND IS UNABLE TO FORM AN OPINION AS TO THE RELEVANCY OF THE PATIENT'S HISTORY TO THE EVENT REPORTED. ANS DEFERS TO THE PATIENT'S PHYSICIAN REGARDING MEDICAL HISTORY.
THE PATIENT RECEIVED HER SCS SYSTEM, WHICH INCLUDED AN IPG AND PERCUTANEOUS LEAD, ON (B)(6)2008. IT WAS REPORTED, THE PATIENT WAS FEELING OVERSTIMULATION SENSATIONS. AN EXAMINATION OF THE PATIENT'S SCS SYSTEM FOUND THE LEAD HAD MIGRATED. IN ORDER TO REGAIN THE PROPER STIMULATION PLACEMENT, THE PHYSICIAN ADDED A SECOND LEAD TO THE PATIENT'S SYSTEM. THE PRODUCT WAS NOT RETURNED TO THE MANUFACTURER FOR ANALYSIS. FOLLOW UP ON THE PATIENT FOUND THAT THE PATIENT CONTINUED TO EXPERIENCE OVERSTIMULATION SENSATIONS, BUT ELECTED NOT TO HAVE ANY ADDITION SURGERIES OR DEVICE REVISIONS. NO FURTHER INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OCTRODE PERCUTANEOUS LEAD | SPINAL CORD STIMULATION LEAD | LGW | ADVANCED NEUROMODULATION SYSTEMS | 3186 | 114345 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |